Share
Market Research Report

NEUPOGEN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By IndicationChemotherapy-induced neutropenia in non-myeloid malignancies · Neutropenia in acute myeloid leukemia (AmL) patients post induction or consolidation chemotherapy · Neutropenia post-myeloablative chemotherapy followed by bone marrow transplantation (BMT) · Mobilization of autologous hematopoietic progenitor cells for leukapheresis · Chronic neutropenia (congenital, cyclic, idiopathic) · and Hematopoietic Syndrome of Acute Radiation Syndrome (H-ARS)
  • By Dose Strength300mcg/1mL · 480mcg/1.6mL · 300MGC/0.5mL · and 480mcg/0.8mL
  • By PackagingSingle-use vials and Prefilled syringes
  • By Patient Age GroupPediatric · Adult · and Geriatric
  • By Sales ChannelOnline and Offline
  • By End UserHospitals · Oncology Clinics · Ambulatory Surgical Centers · and Others (Academic & Research Institutions, etc.)
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In11 Mar 2026
  • Report CodeCMI8115
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Neupogen Market, By Indication
      • Global Neupogen Market, By Dose Strength
      • Global Neupogen Market, By Packaging
      • Global Neupogen Market, By Patient Age Group
      • Global Neupogen Market, By Sales Channel
      • Global Neupogen Market, By End User
      • Global Neupogen Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
    • Reimbursement Scenario
    • Epidemiology
    • Pricing Analysis
  4. Global Neupogen Market, By Indication, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Chemotherapy-induced neutropenia in non-myeloid malignancies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Neutropenia in acute myeloid leukemia (AML) patients post-induction or consolidation chemotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Neutropenia post-myeloablative chemotherapy followed by bone marrow transplantation (BMT)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Mobilization of autologous hematopoietic progenitor cells for leukapheresis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Chronic neutropenia (congenital, cyclic, idiopathic)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Hematopoietic Syndrome of Acute Radiation Syndrome (H-ARS)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  5. Global Neupogen Market, By Dose Strength, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • 300mcg/1mL
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • 480mcg/1.6mL
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • 300MGC/0.5mL
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • 480mcg/0.8mL
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  6. Global Neupogen Market, By Packaging, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Single-use vials
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Prefilled syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  7. Global Neupogen Market, By Patient Age Group, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Adult
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Geriatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  8. Global Neupogen Market, By Sales Channel, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Online
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Offline
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  9. Global Neupogen Market, By End User, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Oncology Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Others (Academic & Research Institutions, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  10. Global Neupogen Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  11. Competitive Landscape

    • Amgen Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  12. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  13. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Neupogen Market' - Global forecast to 2033